
PTAB Rejects Flawed Inherency Argument Against Drug Composition Patent, PTAB Litigation Blog
Visit the Jones Day PTAB Litigation Blog.
On February 3, 2017, the PTAB denied a petition by Amneal Pharmaceuticals LLC ("Amneal") to institute an inter partes review of Hospira Inc.’s patent directed to pharmaceutical compositions of the sedative dexmedetomidine.
Read the full article at ptablitigationblog.com.